ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Parkinson Disease Drug Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-19G16049
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and India Parkinson Disease Drug Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Parkinson Disease Drug Market Report & Forecast 2023-2029

Code: QYRE-Auto-19G16049
Report
November 2023
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
India
Teva Pharmaceutical
Boehringer Ingelheim
Merck
Akorn
GSK
Novartis
AbbVie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health

and India Parkinson Disease Drug Market Size

The global Parkinson Disease Drug revenue was US$ 5492 million in 2022 and is forecast to a readjusted size of US$ 8397.5 million by 2029 with a CAGR of 6.2% during the review period (2023-2029).

and India Parkinson Disease Drug Market

and India Parkinson Disease Drug Market

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
In India, the Parkinson Disease Drug revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
This report focuses on global and India Parkinson Disease Drug market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Parkinson Disease Drug will continue to grow rapidly in the future.
Global Parkinson Disease Drug Scope and Market Size
Parkinson Disease Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Parkinson Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Parkinson Disease Drug market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Parkinson Disease Drug Market Report

Report Metric Details
Report Name and India Parkinson Disease Drug Market
Forecasted market size in 2029 US$ 8397.5 million
CAGR 6.2%
Forecasted years 2023 - 2029
Segment by Type
  • Sinemet-CR
  • Trastal
  • Madopar
  • COMT Inhibitor
  • Other
Segment by Application
  • Under 40 Years Old
  • 40-65 Years Old
  • Above 65 Years Old
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Parkinson Disease Drug Market size in 2029?

Ans: The and India Parkinson Disease Drug Market size in 2029 will be US$ 8397.5 million.

What is the and India Parkinson Disease Drug Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Parkinson Disease Drug Market report?

Ans: The main players in the and India Parkinson Disease Drug Market are Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health

What are the Application segmentation covered in the and India Parkinson Disease Drug Market report?

Ans: The Applications covered in the and India Parkinson Disease Drug Market report are Under 40 Years Old, 40-65 Years Old, Above 65 Years Old

What are the Type segmentation covered in the and India Parkinson Disease Drug Market report?

Ans: The Types covered in the and India Parkinson Disease Drug Market report are Sinemet-CR, Trastal, Madopar, COMT Inhibitor, Other

1 Study Coverage
1.1 Parkinson Disease Drug Product Introduction
1.2 Global Parkinson Disease Drug Outlook 2018 VS 2022 VS 2029
1.2.1 Global Parkinson Disease Drug Market Size for the Year 2018-2029
1.2.2 India Parkinson Disease Drug Market Size for the Year 2018-2029
1.3 Parkinson Disease Drug Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Parkinson Disease Drug in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Parkinson Disease Drug Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Parkinson Disease Drug Market Dynamics
1.4.1 Parkinson Disease Drug Industry Trends
1.4.2 Parkinson Disease Drug Market Drivers
1.4.3 Parkinson Disease Drug Market Challenges
1.4.4 Parkinson Disease Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Parkinson Disease Drug by Type
2.1 Parkinson Disease Drug Market Segment by Type
2.1.1 Sinemet-CR
2.1.2 Trastal
2.1.3 Madopar
2.1.4 COMT Inhibitor
2.1.5 Other
2.2 Global Parkinson Disease Drug Market Size by Type (2018, 2022 & 2029)
2.3 Global Parkinson Disease Drug Market Size by Type (2018-2029)
2.4 India Parkinson Disease Drug Market Size by Type (2018, 2022 & 2029)
2.5 India Parkinson Disease Drug Market Size by Type (2018-2029)
3 Parkinson Disease Drug by Application
3.1 Parkinson Disease Drug Market Segment by Application
3.1.1 Under 40 Years Old
3.1.2 40-65 Years Old
3.1.3 Above 65 Years Old
3.2 Global Parkinson Disease Drug Market Size by Application (2018, 2022 & 2029)
3.3 Global Parkinson Disease Drug Market Size by Application (2018-2029)
3.4 India Parkinson Disease Drug Market Size by Application (2018, 2022 & 2029)
3.5 India Parkinson Disease Drug Market Size by Application (2018-2029)
4 Global Parkinson Disease Drug Competitor Landscape by Company
4.1 Global Parkinson Disease Drug Market Size by Company
4.1.1 Global Key Companies of Parkinson Disease Drug, Ranked by Revenue (2022)
4.1.2 Global Parkinson Disease Drug Revenue by Player (2018-2023)
4.2 Global Parkinson Disease Drug Concentration Ratio (CR)
4.2.1 Parkinson Disease Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Parkinson Disease Drug in 2022
4.2.3 Global Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Parkinson Disease Drug Head office and Area Served
4.4 Global Key Players of Parkinson Disease Drug, Product and Application
4.5 Global Key Players of Parkinson Disease Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Parkinson Disease Drug Market Size by Company
4.7.1 Key Players of Parkinson Disease Drug in India, Ranked by Revenue (2022)
4.7.2 India Parkinson Disease Drug Revenue by Players (2021, 2022 & 2023)
5 Global Parkinson Disease Drug Market Size by Region
5.1 Global Parkinson Disease Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Parkinson Disease Drug Market Size by Region (2018-2029)
5.2.1 Global Parkinson Disease Drug Market Size by Region: 2018-2023
5.2.2 Global Parkinson Disease Drug Market Size by Region (2024-2029)
6 Americas
6.1 Americas Parkinson Disease Drug Market Size YoY Growth 2018-2029
6.2 Americas Parkinson Disease Drug Market Size by Type
6.2.1 Americas Parkinson Disease Drug Market Size by Type (2018-2023)
6.2.2 Americas Parkinson Disease Drug Market Size by Type (2024-2029)
6.2.3 Americas Parkinson Disease Drug Market Share by Type (2018-2029)
6.3 Americas Parkinson Disease Drug Market Size by Application
6.3.1 Americas Parkinson Disease Drug Market Size by Application (2018-2023)
6.3.2 Americas Parkinson Disease Drug Market Size by Application (2024-2029)
6.3.3 Americas Parkinson Disease Drug Market Share by Application (2018-2029)
6.4 Americas Parkinson Disease Drug Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Parkinson Disease Drug Market Size YoY Growth 2018-2029
7.2 EMEA Parkinson Disease Drug Market Size by Type
7.2.1 EMEA Parkinson Disease Drug Market Size by Type (2018-2023)
7.2.2 EMEA Parkinson Disease Drug Market Size by Type (2024-2029)
7.2.3 EMEA Parkinson Disease Drug Market Share by Type (2018-2029)
7.3 EMEA Parkinson Disease Drug Market Size by Application
7.3.1 EMEA Parkinson Disease Drug Market Size by Application (2018-2023)
7.3.2 EMEA Parkinson Disease Drug Market Size by Application (2024-2029)
7.3.3 EMEA Parkinson Disease Drug Market Share by Application (2018-2029)
7.4 EMEA Parkinson Disease Drug Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Parkinson Disease Drug Market Size YoY Growth 2018-2029
8.2 China Parkinson Disease Drug Market Size by Type
8.2.1 China Parkinson Disease Drug Market Size by Type (2018-2023)
8.2.2 China Parkinson Disease Drug Market Size by Type (2024-2029)
8.2.3 China Parkinson Disease Drug Market Share by Type (2018-2029)
8.3 China Parkinson Disease Drug Market Size by Application
8.3.1 China Parkinson Disease Drug Market Size by Application (2018-2023)
8.3.2 China Parkinson Disease Drug Market Size by Application (2024-2029)
8.3.3 China Parkinson Disease Drug Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Parkinson Disease Drug Market Size YoY Growth 2018-2029
9.2 APAC Parkinson Disease Drug Market Size by Type
9.2.1 APAC Parkinson Disease Drug Market Size by Type (2018-2023)
9.2.2 APAC Parkinson Disease Drug Market Size by Type (2024-2029)
9.2.3 APAC Parkinson Disease Drug Market Share by Type (2018-2029)
9.3 APAC Parkinson Disease Drug Market Size by Application
9.3.1 APAC Parkinson Disease Drug Market Size by Application (2018-2023)
9.3.2 APAC Parkinson Disease Drug Market Size by Application (2024-2029)
9.3.3 APAC Parkinson Disease Drug Market Share by Application (2018-2029)
9.4 APAC Parkinson Disease Drug Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Merck
10.1.1 Merck Company Details
10.1.2 Merck Business Overview
10.1.3 Merck Parkinson Disease Drug Introduction
10.1.4 Merck Revenue in Parkinson Disease Drug Business (2018-2023)
10.1.5 Merck Recent Development
10.2 Akorn
10.2.1 Akorn Company Details
10.2.2 Akorn Business Overview
10.2.3 Akorn Parkinson Disease Drug Introduction
10.2.4 Akorn Revenue in Parkinson Disease Drug Business (2018-2023)
10.2.5 Akorn Recent Development
10.3 GSK
10.3.1 GSK Company Details
10.3.2 GSK Business Overview
10.3.3 GSK Parkinson Disease Drug Introduction
10.3.4 GSK Revenue in Parkinson Disease Drug Business (2018-2023)
10.3.5 GSK Recent Development
10.4 Novartis
10.4.1 Novartis Company Details
10.4.2 Novartis Business Overview
10.4.3 Novartis Parkinson Disease Drug Introduction
10.4.4 Novartis Revenue in Parkinson Disease Drug Business (2018-2023)
10.4.5 Novartis Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Details
10.5.2 Boehringer Ingelheim Business Overview
10.5.3 Boehringer Ingelheim Parkinson Disease Drug Introduction
10.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2018-2023)
10.5.5 Boehringer Ingelheim Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Details
10.6.2 Teva Pharmaceutical Business Overview
10.6.3 Teva Pharmaceutical Parkinson Disease Drug Introduction
10.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2018-2023)
10.6.5 Teva Pharmaceutical Recent Development
10.7 Abbvie
10.7.1 Abbvie Company Details
10.7.2 Abbvie Business Overview
10.7.3 Abbvie Parkinson Disease Drug Introduction
10.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2018-2023)
10.7.5 Abbvie Recent Development
10.8 Kyowa Hakko Kirin Pharma
10.8.1 Kyowa Hakko Kirin Pharma Company Details
10.8.2 Kyowa Hakko Kirin Pharma Business Overview
10.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Introduction
10.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2018-2023)
10.8.5 Kyowa Hakko Kirin Pharma Recent Development
10.9 Astellas Pharma
10.9.1 Astellas Pharma Company Details
10.9.2 Astellas Pharma Business Overview
10.9.3 Astellas Pharma Parkinson Disease Drug Introduction
10.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2018-2023)
10.9.5 Astellas Pharma Recent Development
10.10 Desitin Arzneimittel
10.10.1 Desitin Arzneimittel Company Details
10.10.2 Desitin Arzneimittel Business Overview
10.10.3 Desitin Arzneimittel Parkinson Disease Drug Introduction
10.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2018-2023)
10.10.5 Desitin Arzneimittel Recent Development
10.11 Endo Pharmaceuticals
10.11.1 Endo Pharmaceuticals Company Details
10.11.2 Endo Pharmaceuticals Business Overview
10.11.3 Endo Pharmaceuticals Parkinson Disease Drug Introduction
10.11.4 Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2018-2023)
10.11.5 Endo Pharmaceuticals Recent Development
10.12 F.Hoffmann-La Roche
10.12.1 F.Hoffmann-La Roche Company Details
10.12.2 F.Hoffmann-La Roche Business Overview
10.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Introduction
10.12.4 F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2018-2023)
10.12.5 F.Hoffmann-La Roche Recent Development
10.13 H.Lundbeck
10.13.1 H.Lundbeck Company Details
10.13.2 H.Lundbeck Business Overview
10.13.3 H.Lundbeck Parkinson Disease Drug Introduction
10.13.4 H.Lundbeck Revenue in Parkinson Disease Drug Business (2018-2023)
10.13.5 H.Lundbeck Recent Development
10.14 Valeant
10.14.1 Valeant Company Details
10.14.2 Valeant Business Overview
10.14.3 Valeant Parkinson Disease Drug Introduction
10.14.4 Valeant Revenue in Parkinson Disease Drug Business (2018-2023)
10.14.5 Valeant Recent Development
10.15 Apokyn
10.15.1 Apokyn Company Details
10.15.2 Apokyn Business Overview
10.15.3 Apokyn Parkinson Disease Drug Introduction
10.15.4 Apokyn Revenue in Parkinson Disease Drug Business (2018-2023)
10.15.5 Apokyn Recent Development
10.16 Orion
10.16.1 Orion Company Details
10.16.2 Orion Business Overview
10.16.3 Orion Parkinson Disease Drug Introduction
10.16.4 Orion Revenue in Parkinson Disease Drug Business (2018-2023)
10.16.5 Orion Recent Development
10.17 Stada Arzneimittel
10.17.1 Stada Arzneimittel Company Details
10.17.2 Stada Arzneimittel Business Overview
10.17.3 Stada Arzneimittel Parkinson Disease Drug Introduction
10.17.4 Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2018-2023)
10.17.5 Stada Arzneimittel Recent Development
10.18 US WorldMeds
10.18.1 US WorldMeds Company Details
10.18.2 US WorldMeds Business Overview
10.18.3 US WorldMeds Parkinson Disease Drug Introduction
10.18.4 US WorldMeds Revenue in Parkinson Disease Drug Business (2018-2023)
10.18.5 US WorldMeds Recent Development
10.19 Bausch Health
10.19.1 Bausch Health Company Details
10.19.2 Bausch Health Business Overview
10.19.3 Bausch Health Parkinson Disease Drug Introduction
10.19.4 Bausch Health Revenue in Parkinson Disease Drug Business (2018-2023)
10.19.5 Bausch Health Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
India
Teva Pharmaceutical
Boehringer Ingelheim
Merck
Akorn
GSK
Novartis
AbbVie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
List of Tables
    Table 1. Parkinson Disease Drug Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Parkinson Disease Drug Market Trends
    Table 3. Parkinson Disease Drug Market Drivers
    Table 4. Parkinson Disease Drug Market Challenges
    Table 5. Parkinson Disease Drug Market Restraints
    Table 6. Global Parkinson Disease Drug Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Parkinson Disease Drug Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Parkinson Disease Drug Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Parkinson Disease Drug Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Parkinson Disease Drug, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Parkinson Disease Drug Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Parkinson Disease Drug Revenue Share by Player, 2018-2023
    Table 13. Global Parkinson Disease Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Parkinson Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2022)
    Table 15. Global Key Players of Parkinson Disease Drug, Headquarters and Area Served
    Table 16. Global Key Players of Parkinson Disease Drug, Product and Application
    Table 17. Global Key Players of Parkinson Disease Drug, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Parkinson Disease Drug in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Parkinson Disease Drug Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Parkinson Disease Drug Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Parkinson Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Parkinson Disease Drug Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Parkinson Disease Drug Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Parkinson Disease Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Parkinson Disease Drug Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Parkinson Disease Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Parkinson Disease Drug Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Parkinson Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Parkinson Disease Drug Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Parkinson Disease Drug Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Parkinson Disease Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Parkinson Disease Drug Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Parkinson Disease Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Parkinson Disease Drug Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Parkinson Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Parkinson Disease Drug Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Parkinson Disease Drug Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Parkinson Disease Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Parkinson Disease Drug Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Parkinson Disease Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Parkinson Disease Drug Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Parkinson Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Parkinson Disease Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Parkinson Disease Drug Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Parkinson Disease Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Parkinson Disease Drug Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Parkinson Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Parkinson Disease Drug Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Parkinson Disease Drug Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Merck Company Details
    Table 52. Merck Business Overview
    Table 53. Merck Parkinson Disease Drug Product
    Table 54. Merck Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 55. Merck Recent Development
    Table 56. Akorn Company Details
    Table 57. Akorn Business Overview
    Table 58. Akorn Parkinson Disease Drug Product
    Table 59. Akorn Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 60. Akorn Recent Development
    Table 61. GSK Company Details
    Table 62. GSK Business Overview
    Table 63. GSK Parkinson Disease Drug Product
    Table 64. GSK Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 65. GSK Recent Development
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Parkinson Disease Drug Product
    Table 69. Novartis Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Boehringer Ingelheim Company Details
    Table 72. Boehringer Ingelheim Business Overview
    Table 73. Boehringer Ingelheim Parkinson Disease Drug Product
    Table 74. Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 75. Boehringer Ingelheim Recent Development
    Table 76. Teva Pharmaceutical Company Details
    Table 77. Teva Pharmaceutical Business Overview
    Table 78. Teva Pharmaceutical Parkinson Disease Drug Product
    Table 79. Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 80. Teva Pharmaceutical Recent Development
    Table 81. Abbvie Company Details
    Table 82. Abbvie Business Overview
    Table 83. Abbvie Parkinson Disease Drug Product
    Table 84. Abbvie Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 85. Abbvie Recent Development
    Table 86. Kyowa Hakko Kirin Pharma Company Details
    Table 87. Kyowa Hakko Kirin Pharma Business Overview
    Table 88. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product
    Table 89. Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 90. Kyowa Hakko Kirin Pharma Recent Development
    Table 91. Astellas Pharma Company Details
    Table 92. Astellas Pharma Business Overview
    Table 93. Astellas Pharma Parkinson Disease Drug Product
    Table 94. Astellas Pharma Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 95. Astellas Pharma Recent Development
    Table 96. Desitin Arzneimittel Company Details
    Table 97. Desitin Arzneimittel Business Overview
    Table 98. Desitin Arzneimittel Parkinson Disease Drug Product
    Table 99. Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 100. Desitin Arzneimittel Recent Development
    Table 101. Endo Pharmaceuticals Company Details
    Table 102. Endo Pharmaceuticals Business Overview
    Table 103. Endo Pharmaceuticals Parkinson Disease Drug Product
    Table 104. Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 105. Endo Pharmaceuticals Recent Development
    Table 106. F.Hoffmann-La Roche Company Details
    Table 107. F.Hoffmann-La Roche Business Overview
    Table 108. F.Hoffmann-La Roche Parkinson Disease Drug Product
    Table 109. F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 110. F.Hoffmann-La Roche Recent Development
    Table 111. H.Lundbeck Company Details
    Table 112. H.Lundbeck Business Overview
    Table 113. H.Lundbeck Parkinson Disease Drug Product
    Table 114. H.Lundbeck Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 115. H.Lundbeck Recent Development
    Table 116. Valeant Company Details
    Table 117. Valeant Business Overview
    Table 118. Valeant Parkinson Disease Drug Product
    Table 119. Valeant Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 120. Valeant Recent Development
    Table 121. Apokyn Company Details
    Table 122. Apokyn Business Overview
    Table 123. Apokyn Parkinson Disease Drug Product
    Table 124. Apokyn Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 125. Apokyn Recent Development
    Table 126. Orion Company Details
    Table 127. Orion Business Overview
    Table 128. Orion Parkinson Disease Drug Product
    Table 129. Orion Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 130. Orion Recent Development
    Table 131. Stada Arzneimittel Company Details
    Table 132. Stada Arzneimittel Business Overview
    Table 133. Stada Arzneimittel Parkinson Disease Drug Product
    Table 134. Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 135. Stada Arzneimittel Recent Development
    Table 136. US WorldMeds Company Details
    Table 137. US WorldMeds Business Overview
    Table 138. US WorldMeds Parkinson Disease Drug Product
    Table 139. US WorldMeds Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 140. US WorldMeds Recent Development
    Table 141. Bausch Health Company Details
    Table 142. Bausch Health Business Overview
    Table 143. Bausch Health Parkinson Disease Drug Product
    Table 144. Bausch Health Revenue in Parkinson Disease Drug Business (2018-2023) & (US$ Million)
    Table 145. Bausch Health Recent Development
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Parkinson Disease Drug Product Picture
    Figure 2. Global Parkinson Disease Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Parkinson Disease Drug Market Size 2018-2029 (US$ Million)
    Figure 4. India Parkinson Disease Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Parkinson Disease Drug Market Size 2018-2029 (US$ Million)
    Figure 6. India Parkinson Disease Drug Market Share in Global 2018-2029
    Figure 7. Parkinson Disease Drug Report Years Considered
    Figure 8. Product Picture of Sinemet-CR
    Figure 9. Product Picture of Trastal
    Figure 10. Product Picture of Madopar
    Figure 11. Product Picture of COMT Inhibitor
    Figure 12. Product Picture of Other
    Figure 13. Global Parkinson Disease Drug Market Share by Type in 2022 & 2029
    Figure 14. Global Parkinson Disease Drug Market Size by Type (2018-2029) & (US$ Million)
    Figure 15. Global Parkinson Disease Drug Market Share by Type (2018-2029)
    Figure 16. India Parkinson Disease Drug Market Share by Type in 2022 & 2029
    Figure 17. India Parkinson Disease Drug Market Size by Type (2018-2029) & (US$ Million)
    Figure 18. India Parkinson Disease Drug Market Share by Type (2018-2029)
    Figure 19. Product Picture of Under 40 Years Old
    Figure 20. Product Picture of 40-65 Years Old
    Figure 21. Product Picture of Above 65 Years Old
    Figure 22. Global Parkinson Disease Drug Market Share by Application in 2022 & 2029
    Figure 23. Global Parkinson Disease Drug Market Size by Application (2018-2029) & (US$ Million)
    Figure 24. Global Parkinson Disease Drug Market Share by Application (2018-2029)
    Figure 25. India Parkinson Disease Drug Market Share by Application in 2022 & 2029
    Figure 26. India Parkinson Disease Drug Market Size by Application (2018-2029) & (US$ Million)
    Figure 27. India Parkinson Disease Drug Market Share by Application (2018-2029)
    Figure 28. The Top 5 and 10 Largest Companies of Parkinson Disease Drug in the World: Market Share by Parkinson Disease Drug Revenue in 2022
    Figure 29. Global Parkinson Disease Drug Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 30. Global Parkinson Disease Drug Market Share by Region (2018-2029)
    Figure 31. Americas Parkinson Disease Drug Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 32. Americas Parkinson Disease Drug Market Share by Type (2018-2029)
    Figure 33. Americas Parkinson Disease Drug Market Share by Application (2018-2029)
    Figure 34. United States Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Canada Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Mexico Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Brazil Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 38. EMEA Parkinson Disease Drug Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 39. EMEA Parkinson Disease Drug Market Share by Type (2018-2029)
    Figure 40. EMEA Parkinson Disease Drug Market Share by Application (2018-2029)
    Figure 41. Europe Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Middle East Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Africa Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 44. China Parkinson Disease Drug Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 45. China Parkinson Disease Drug Market Share by Type (2018-2029)
    Figure 46. China Parkinson Disease Drug Market Share by Application (2018-2029)
    Figure 47. APAC Parkinson Disease Drug Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 48. APAC Parkinson Disease Drug Market Share by Type (2018-2029)
    Figure 49. APAC Parkinson Disease Drug Market Share by Application (2018-2029)
    Figure 50. Japan Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 51. South Korea Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. China Taiwan Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Southeast Asia Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 54. India Parkinson Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Merck Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 56. Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 57. GSK Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 58. Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 59. Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 60. Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 61. Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 62. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 63. Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 64. Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 65. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 66. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 67. H.Lundbeck Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 68. Valeant Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 69. Apokyn Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 70. Orion Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 71. Stada Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 72. US WorldMeds Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 73. Bausch Health Revenue Growth Rate in Parkinson Disease Drug Business (2018-2023)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions